1,319
Views
105
CrossRef citations to date
0
Altmetric
Original

Epidemiology of haemoglobin disorders in Europe: an overview

, , , , , , , , , & show all
Pages 39-70 | Published online: 08 Jul 2009

References

  • Weatherall D. J., Clegg J. B. The thalassaemia syndromes. Oxford, Blackwell Science, 4th edn
  • The Haemoglobinopathies in Europe, WHO Regional Office for Europe, unpublished document IPC/MCH 110. 1988
  • Modell B., . EC concerted action on developing patient registers as a tool for improving service delivery for haemoglobin disorders. Health Services Research, G. N Fracchia, M Theophilatou, et al. IOS Amsterdam Press, Amsterdam 1993
  • UK National Screening Programme. Available at: http://www.nsc.nhs.uk
  • UK Sickle Cell and Thalassaemia Screening Programme. Available at: http://www‐phm.umds.ac.uk/haemscreening/
  • Boletini E. 1991; 9–11, and personal communications, The haemoglobinopathies in Albania. Proceedings of the meeting of the Mediterranean Blood Club, Milan, Italy
  • Angastiniotis M. A., Hadjiminas M. G. Prevention of thalassaemia in Cyprus. Lancet 1981; 1: 369–70
  • Efremov G. D., Juricic D., Stojanovski N. Hemoglobinopathies in Yugoslavia. Hemoglobin 1982; 6: 643–51
  • Malamos B., Fessas Ph., Stamatoyannopoulos G. Types of thalassaemia trait carriers as revealed by their incidence in Greece. Br J Haematol 1962; 8: 5
  • Personal communications: Dr Zurlo, Dr Angelo Rossi‐Mori, and many other colleagues
  • Grech J., Felice A. Personal communications and Scerri CA, Abela W, Galdies R, Pizzuto M, Grech JL, Felice AE. The beta+IVS, I‐NT no. 6 (T–>C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta. Br J Haematol. 1993; 83: 669–71
  • Martins M. C., Olim G., Melo J., Magalhaes H. A., Rodrigues M. O. Hereditary anaemias in Portugal: epidemiology, public health significance and control. J Med Genet 1993; 30: 235–9
  • Amselem S., Nunes V., Vidaud M., Estivill X., Wong C., d'Auriol L., et al. Determination of the spectrum of beta‐thalassemia genes in Spain by use of dot‐blot analysis of amplified beta‐globin DNA. Am J Hum Genet 1988; 43: 95–100
  • Akar N., Personal communication 1999 (1997 data)
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders, and derived service indicators. Submitted for publication 2006. Updated information for the UK is available at: http://www.pegasus.nhs.uk
  • Health Education Authority. Sickle Cell and Thalassaemia: achieving health gain. Guidance for commissioners and providers. London, Health Education Authority 1998
  • Hickman M., Modell B., Greengross P., Chapman C., Layton M., Gill M., Davies S. Mapping the prevalence of beta thalassaemia and sickle cell haemoglobin in England: recommended rates for local service planning. Br J Haematol 1999; 104: 860–7
  • Wonke B., Modell M., Marlow T., Khan M., Modell B. Microcytosis, iron deficiency and thalassaemia in a multi‐ethnic community: a pilot study. Scand J Clin Lab Invest 2007; 67: 87–95
  • Modell B., Darr A. Genetic counselling and customary consanguineous marriage. Nature Rev Genet 2002; 3: 225–9
  • United Nations Demographic Yearbook. 2003. United Nations, New York. Available at: http://unstats.un.org/unsd/demographic/products/dyb/dyb2.htm
  • United Nations Demographic Yearbook. Historical Supplement. United Nations, New York; 1997. Available at: http://unstats.un.org/unsd/demographic/products/dyb/dybhist.htm
  • UK national statistics online. Available at: http://www.statistics.gov.uk/
  • Denmark national statistics. Available at: http://www.dst.dk/
  • Norway national statistics. Available at: http://www.ssb.no/
  • Organisation for Economic Co‐operation and Development. Statistics. Available at: www.oecd.org
  • Bodmer W. F., Cavalli‐Sforza L. L. Genetics, evolution, and man. W. H. Freeman, San Francisco 1976
  • Bittles AH. Consanguineous marriage: current global incidence and its relevance to demographic research. Population Studies Center, University of Michigan. 1990. Research report no. 90–186. Updated data available at www.consang.org
  • Darr A., Modell B. The frequency of consanguineous marriage among British Pakistanis. J Med Genet 1988; 25: 186–90
  • Taven C. Les immigres en France: une situation qui evolue. INSEE Premiere 1042. Sept 2005. Available at: www.insee.fr
  • Imamura T., Sugihara J., Matsuo T., Maruyama T., Ohta Y., Sumida I., et al. Frequency and distribution of structural variants of hemoglobin and thalassemic states in Western Japan. Hemoglobin 1980; 4: 409–15
  • Iuchi I. Abnormal hemoglobin in Japan: biochemical and epidemiologic characters of abnormal hemoglobin in Japan. Acta Haematol Jpn 1968; 31: 842–51
  • Cook A. I., Lehmann H. Beta thalassaemia and some rare haemoglobin variants in the highlands of Scotland. Scott Med J 1973; 18: 14–20
  • Knox‐MacAulay H. H. M., Weatherall D. J., Clegg J. B., Pembrey M. E. Thalassaemia in the British. Br Med J 1973; 3: 150
  • Vetter B., Schwarz C., Kohne E., Kulozik A. E. Beta‐thalassaemia in the immigrant and non‐immigrant German populations. Br J Haematol 1997; 266–72
  • Giordano P. C., Harteveld C. L., Heister A. J., Batelaan D., van Delft P., Plug R., et al. The molecular spectrum of beta‐thalassemia and abnormal hemoglobins in the allochthonous and autochthonous Dutch population. Commun Genet 1998; 1: 243–51
  • Irenge L. M., Heuterspreute M., Philippe M., Derclaye I., Robert A., Gala J. L. Beta‐thalassaemia in indigenous Belgians: an update. Acta Clin Belg 1997; 52: 171–5
  • Modell B., Khan M., Darlison M., King A., Layton M., Old J., et al. Use of a national diagnosis register for surveillance of an inherited disorder: the example of beta thalassaemia in the United Kingdom. Bull WHO 2001; 79: 1006–13
  • Modell B., Darlison M., Epidemiology of haemoglobin disorders in England and Wales. In preparation
  • Karnon J., Zeuner D., Brown J., Ades A. E., Wonke B., Modell B. Lifetime treatment costs of beta‐thalassaemia major. Clin Lab Haematol 1999; 21: 377–85
  • Karnon J., Zeuner D., Ades A. E., Efimba W., Brown J., Yardumian A. The effects of neonatal screening for sickle cell disorders on lifetime treatment costs and early deaths avoided: a modelling approach. J Public Health Med 2000; 22: 500–11
  • Zeuner D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN. 1999. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. NHS R&D HTA Programme. Available at: www.hta.nhsweb.nhs.uk
  • Cario H., Stahnke K., Sander S., Kohne E. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta‐thalassemia study. Ann Hematol 2000; 79: 7–12
  • Higgs D. R., Vickers M. A., Wilkie A. O. M., Pretorius I. M., Jarman A. P., Weatherall D. J. A review of the molecular genetics of the human alpha globin gene cluster. Blood 1989; 73: 1081–104
  • Loukopoulos D. Current status of thalassaemia and the sickle cell syndromes in Greece. Semin Hematol 1996; 33: 76–86
  • Cao A., Furbetta M., Galanello R., Melis M. A., Angius A., Ximenes A., et al. Prevention of homozygous β‐thalassaemia by carrier screening and prenatal diagnosis in Sardinia. Am J Human Genet 1981; 33: 592–605
  • Maggio A., Caronia F., Orlandi F. Prenatal diagnosis of haemoglobinopathies in Sicily. Lancet 1992; 339: 1361–2
  • Angastiniotis M. A., Hadjiminas M. G. Prevention of thalassaemia in Cyprus. Lancet 1981; 1: 369–70
  • Canatan D., Kose M. R., Ustundag M., Haznedaroglu D., Ozbas S. Hemoglobinopathy control program in Turkey. Community Genet 2006; 9: 124–6
  • Cario H., Stahnke K., Sander S., Kohne E. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta‐thalassemia study. Ann Hematol 2000; 79: 7–12
  • Dickerhoff R., von Rucker A., Kohne E. Sichelzellerkrakungen in Deutchschland. Verlufsbeobachtungen uber zehn jahre. Deutsches Artzeblatt 1998; 95: 26. A‐1675‐8
  • Gulbis B., Ferster A., Cotton F., Lebouchard M. P., Cochaux P., Vertongen F. Neonatal haemoglobinopathy screening: review of a 10‐year programme in Brussels. J Med Screen, In press
  • Giordano P. C., Plancke A., Van Meir C. A., Janssen C. A. H., Kok P. J. M. J., Van Rooijen‐Nijdam I. H., et al. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenatal Diagnosis, In press
  • Standards for the clinical care of children and adults with thalassaemia in the UK. 2005, The UK Thalassaemia Society
  • Professional education for genetic assessment and screening (PEGASUS). Available at: www.pegasus.nhs.uk/
  • Accessible publishing of genetic information (APoGI). Available at: www.chime.ucl.ac.uk/
  • WHO. 2004, The molecular genetic epidemiology of cystic fibrosis. Report of a joint meeting of WHO/ECFTN/ICF/(M)A/ECFS. Genoa, Italy, 19 June 2002. WHO/HGN/CF/WG/04.02

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.